Industry Research Reports
Home > Reports > Chemical & Material > Global Gamma Valerolactone Market Outlook, In‑Depth Analysis & Forecast to 2032
Global Gamma Valerolactone Market Outlook, In‑Depth Analysis & Forecast to 2032
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Gamma Valerolactone Market Size(US$)
CAGR 2026-2032
2.8%
Market Size,2032
USD 731
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 619 million
Market Forecast in 2032(Value)
US$ 731 million
CAGR
2.8%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Gamma Valerolactone market is projected to grow from US$ 603 million in 2025 to US$ 731 million by 2032, at a CAGR of 2.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Gamma Valerolactone, commonly abbreviated as GVL, is a five-membered cyclic ester with the molecular formula C5H8O2 and CAS number 108-29-2. It is generally supplied as a colorless to pale-yellow liquid and is used in food flavors, fragrance formulations, industrial solvents, pharmaceutical and fine-chemical synthesis, polymer intermediates, lubricants, plasticizers and energy-related chemicals. GVL can be manufactured through the catalytic hydrogenation and cyclization of levulinic acid or levulinate esters using biomass-derived or petrochemical feedstocks. In 2025, global Gamma Valerolactone production reached approximately 26.5 K MT.
Gamma-valerolactone (GVL) is a renewable organic compound derived mainly from biomass sources such as lignocellulosic materials. It serves as a versatile green solvent, fuel additive, and intermediate in the production of chemicals, polymers, and pharmaceuticals. Its environmentally friendly profile, biodegradability, and relatively low toxicity make it attractive in applications where sustainable alternatives are sought to replace petroleum-based solvents and intermediates. GVL is also being explored as a platform molecule for producing biofuels and value-added chemicals, further enhancing its strategic importance in the shift toward a circular and bio-based economy.
The market for gamma-valerolactone is driven by the growing demand for green solvents in industrial processes, the need for sustainable fuel additives, and the rising interest in bio-based chemicals. Key end-use industries include chemicals, energy, pharmaceuticals, and agrochemicals, with research and development playing a significant role in expanding its commercial viability. However, challenges such as high production costs and limited large-scale manufacturing capacity currently restrict its widespread adoption. As advances in biomass conversion technologies mature and scale up, the market is expected to expand steadily, with strong opportunities in regions focusing on renewable energy and sustainable chemical production.
MARKET SEGMENTATION
By Company
- Soda Aromatic
- Anhui Hyea Aromas
- LangFang Hawk T&D
- Chongqing Zoteq Aromachemical
- Jiangsu Qingquan Chemical
- Juye Zhongyue Aroma
- Kunshan Baihua Biotechnology
- Inoue Perfumery MFG
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Food Grade
- Industrial Grade
Segment by Application
- Food Flavors
- Solvent
- Monomer Intermediate
- Others
Segment by Category
- Chemical Method
- Biological Method
Segment by Division
- Direct Selling
- Distribution
REPORT SCOPE
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Gamma Valerolactone market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (capacity, sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
CHAPTER OUTLINE
Chapter 1: Defines the Gamma Valerolactone study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue, sales, and production to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: Maps global production capacity, utilization, and market share (2021–2032), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks
Chapter 7: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 8: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 9: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 10: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 11: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth: details product specs, capacity, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 13: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles
Chapter 14: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 7-11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Gamma Valerolactone: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Gamma Valerolactone Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Food Grade
1.2.3 Industrial Grade
1.3 Market Segmentation by Method
1.3.1 Global Gamma Valerolactone Market Size by Method, 2021 vs 2025 vs 2032
1.3.2 Chemical Method
1.3.3 Biological Method
1.4 Market Segmentation by Channel
1.4.1 Global Gamma Valerolactone Market Size by Channel, 2021 vs 2025 vs 2032
1.4.2 Direct Selling
1.4.3 Distribution
1.5 Market Segmentation by Application
1.5.1 Global Gamma Valerolactone Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Food Flavors
1.5.3 Solvent
1.5.4 Monomer Intermediate
1.5.5 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Gamma Valerolactone Revenue Estimates and Forecasts (2021-2032)
2.2 Global Gamma Valerolactone Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Gamma Valerolactone Sales Estimates and Forecasts (2021-2032)
2.4 Global Gamma Valerolactone Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Global Sales Market Share by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.5 Global Gamma Valerolactone Production Capacity and Utilization (2021 vs 2025 vs 2032)
2.6 Production Comparison by Region: 2021 vs 2025 vs 2032
3 Competitive Landscape
3.1 Global Gamma Valerolactone Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Gamma Valerolactone Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs. 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Food Grade: Market Share by Key Manufacturers
3.5.2 Industrial Grade: Market Share by Key Manufacturers
3.6 Global Gamma Valerolactone Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Market Entry and Exit Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Product Segmentation
4.1 Global Gamma Valerolactone Sales Performance by Type
4.1.1 Global Gamma Valerolactone Sales Volume by Type (2021-2032)
4.1.2 Global Gamma Valerolactone Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global Gamma Valerolactone Sales Performance by Method
4.2.1 Global Gamma Valerolactone Sales Volume by Method (2021-2032)
4.2.2 Global Gamma Valerolactone Revenue by Method (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Method (2021-2032)
4.3 Global Gamma Valerolactone Sales Performance by Channel
4.3.1 Global Gamma Valerolactone Sales Volume by Channel (2021-2032)
4.3.2 Global Gamma Valerolactone Revenue by Channel (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by Channel (2021-2032)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Gamma Valerolactone Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Gamma Valerolactone Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 Global Production Analysis
6.1 Global Gamma Valerolactone Production Capacity and Utilization Rates (2021–2032)
6.2 Regional Production Dynamics and Outlook
6.2.1 Historic Production by Region (2021-2026)
6.2.2 Forecasted Production by Region (2027-2032)
6.2.3 Production Market Share by Region (2021-2032)
6.2.4 Regulatory and Trade Policy Impact on Production
6.2.5 Production Capacity Enablers and Constraints
6.3 Key Regional Production Hubs
6.3.1 North America
6.3.2 Europe
6.3.3 China
6.3.4 Japan
7 North America
7.1 North America Sales Volume and Revenue (2021-2032)
7.2 North America Key Manufacturers Sales Revenue in 2025
7.3 North America Gamma Valerolactone Sales and Revenue by Application (2021-2032)
7.4 North America Growth Accelerators and Market Barriers
7.5 North America Gamma Valerolactone Market Size by Country
7.5.1 North America Revenue by Country
7.5.2 North America Sales Trends by Country
7.5.3 US
7.5.4 Canada
7.5.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2021-2032)
8.2 Europe Key Manufacturers Sales Revenue in 2025
8.3 Europe Gamma Valerolactone Sales and Revenue by Application (2021-2032)
8.4 Europe Growth Accelerators and Market Barriers
8.5 Europe Gamma Valerolactone Market Size by Country
8.5.1 Europe Revenue by Country
8.5.2 Europe Sales Trends by Country
8.5.3 Germany
8.5.4 France
8.5.5 U.K.
8.5.6 Italy
8.5.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
9.3 Asia-Pacific Gamma Valerolactone Sales and Revenue by Application (2021-2032)
9.4 Asia-Pacific Gamma Valerolactone Market Size by Region
9.4.1 Asia-Pacific Revenue by Region
9.4.2 Asia-Pacific Sales Trends by Region
9.5 Asia-Pacific Growth Accelerators and Market Barriers
9.6 Southeast Asia
9.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
9.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.7 China
9.8 Japan
9.9 South Korea
9.10 China Taiwan
9.11 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2021-2032)
10.2 Central and South America Key Manufacturers Sales Revenue in 2025
10.3 Central and South America Gamma Valerolactone Sales and Revenue by Application (2021-2032)
10.4 Central and South America Investment Opportunities and Key Challenges
10.5 Central and South America Gamma Valerolactone Market Size by Country
10.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 Brazil
10.5.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
11.3 Middle East and Africa Gamma Valerolactone Sales and Revenue by Application (2021-2032)
11.4 Middle East and Africa Investment Opportunities and Key Challenges
11.5 Middle East and Africa Gamma Valerolactone Market Size by Country
11.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
11.5.2 GCC Countries
11.5.3 Turkey
11.5.4 Egypt
11.5.5 South Africa
12 Corporate Profile
12.1 Soda Aromatic
12.1.1 Soda Aromatic Corporation Information
12.1.2 Soda Aromatic Business Overview
12.1.3 Soda Aromatic Gamma Valerolactone Product Models, Descriptions and Specifications
12.1.4 Soda Aromatic Gamma Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.1.5 Soda Aromatic Gamma Valerolactone Sales by Product in 2025
12.1.6 Soda Aromatic Gamma Valerolactone Sales by Application in 2025
12.1.7 Soda Aromatic Gamma Valerolactone Sales by Geographic Area in 2025
12.1.8 Soda Aromatic Gamma Valerolactone SWOT Analysis
12.1.9 Soda Aromatic Recent Developments
12.2 Anhui Hyea Aromas
12.2.1 Anhui Hyea Aromas Corporation Information
12.2.2 Anhui Hyea Aromas Business Overview
12.2.3 Anhui Hyea Aromas Gamma Valerolactone Product Models, Descriptions and Specifications
12.2.4 Anhui Hyea Aromas Gamma Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.2.5 Anhui Hyea Aromas Gamma Valerolactone Sales by Product in 2025
12.2.6 Anhui Hyea Aromas Gamma Valerolactone Sales by Application in 2025
12.2.7 Anhui Hyea Aromas Gamma Valerolactone Sales by Geographic Area in 2025
12.2.8 Anhui Hyea Aromas Gamma Valerolactone SWOT Analysis
12.2.9 Anhui Hyea Aromas Recent Developments
12.3 LangFang Hawk T&D
12.3.1 LangFang Hawk T&D Corporation Information
12.3.2 LangFang Hawk T&D Business Overview
12.3.3 LangFang Hawk T&D Gamma Valerolactone Product Models, Descriptions and Specifications
12.3.4 LangFang Hawk T&D Gamma Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.3.5 LangFang Hawk T&D Gamma Valerolactone Sales by Product in 2025
12.3.6 LangFang Hawk T&D Gamma Valerolactone Sales by Application in 2025
12.3.7 LangFang Hawk T&D Gamma Valerolactone Sales by Geographic Area in 2025
12.3.8 LangFang Hawk T&D Gamma Valerolactone SWOT Analysis
12.3.9 LangFang Hawk T&D Recent Developments
12.4 Chongqing Zoteq Aromachemical
12.4.1 Chongqing Zoteq Aromachemical Corporation Information
12.4.2 Chongqing Zoteq Aromachemical Business Overview
12.4.3 Chongqing Zoteq Aromachemical Gamma Valerolactone Product Models, Descriptions and Specifications
12.4.4 Chongqing Zoteq Aromachemical Gamma Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.4.5 Chongqing Zoteq Aromachemical Gamma Valerolactone Sales by Product in 2025
12.4.6 Chongqing Zoteq Aromachemical Gamma Valerolactone Sales by Application in 2025
12.4.7 Chongqing Zoteq Aromachemical Gamma Valerolactone Sales by Geographic Area in 2025
12.4.8 Chongqing Zoteq Aromachemical Gamma Valerolactone SWOT Analysis
12.4.9 Chongqing Zoteq Aromachemical Recent Developments
12.5 Jiangsu Qingquan Chemical
12.5.1 Jiangsu Qingquan Chemical Corporation Information
12.5.2 Jiangsu Qingquan Chemical Business Overview
12.5.3 Jiangsu Qingquan Chemical Gamma Valerolactone Product Models, Descriptions and Specifications
12.5.4 Jiangsu Qingquan Chemical Gamma Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.5.5 Jiangsu Qingquan Chemical Gamma Valerolactone Sales by Product in 2025
12.5.6 Jiangsu Qingquan Chemical Gamma Valerolactone Sales by Application in 2025
12.5.7 Jiangsu Qingquan Chemical Gamma Valerolactone Sales by Geographic Area in 2025
12.5.8 Jiangsu Qingquan Chemical Gamma Valerolactone SWOT Analysis
12.5.9 Jiangsu Qingquan Chemical Recent Developments
12.6 Juye Zhongyue Aroma
12.6.1 Juye Zhongyue Aroma Corporation Information
12.6.2 Juye Zhongyue Aroma Business Overview
12.6.3 Juye Zhongyue Aroma Gamma Valerolactone Product Models, Descriptions and Specifications
12.6.4 Juye Zhongyue Aroma Gamma Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.6.5 Juye Zhongyue Aroma Recent Developments
12.7 Kunshan Baihua Biotechnology
12.7.1 Kunshan Baihua Biotechnology Corporation Information
12.7.2 Kunshan Baihua Biotechnology Business Overview
12.7.3 Kunshan Baihua Biotechnology Gamma Valerolactone Product Models, Descriptions and Specifications
12.7.4 Kunshan Baihua Biotechnology Gamma Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.7.5 Kunshan Baihua Biotechnology Recent Developments
12.8 Inoue Perfumery MFG
12.8.1 Inoue Perfumery MFG Corporation Information
12.8.2 Inoue Perfumery MFG Business Overview
12.8.3 Inoue Perfumery MFG Gamma Valerolactone Product Models, Descriptions and Specifications
12.8.4 Inoue Perfumery MFG Gamma Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.8.5 Inoue Perfumery MFG Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Gamma Valerolactone Industry Chain
13.2 Gamma Valerolactone Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Gamma Valerolactone Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Gamma Valerolactone Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Gamma Valerolactone Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
14.4 Impact of U.S. Tariffs
15 Key Findings in the Global Gamma Valerolactone Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Gamma Valerolactone Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Gamma Valerolactone Market Size Growth Rate by Method, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Gamma Valerolactone Market Size Growth Rate by Channel, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Gamma Valerolactone Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Gamma Valerolactone Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Gamma Valerolactone Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (Tons)
Table 7. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 8. Global Gamma Valerolactone Production Growth Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (Tons)
Table 9. Global Gamma Valerolactone Sales by Manufacturers (Tons), 2021-2026
Table 10. Global Gamma Valerolactone Sales Share by Manufacturers (2021-2026)
Table 11. Global Gamma Valerolactone Revenue by Manufacturers (US$ Million), 2021-2026
Table 12. Global Gamma Valerolactone Revenue-Based Market Share by Manufacturers (2021-2026)
Table 13. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 14. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Gamma Valerolactone Revenue, 2025
Table 15. Global Gamma Valerolactone Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 16. Global Gamma Valerolactone Average Selling Price (ASP) by Manufacturers (US$/kg), 2021-2026
Table 17. Key Manufacturers Gamma Valerolactone Manufacturing Base and Headquarters
Table 18. Global Gamma Valerolactone Market Concentration Ratio (CR5)
Table 19. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 20. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 21. Global Gamma Valerolactone Sales Volume by Type (Tons), 2021-2026
Table 22. Global Gamma Valerolactone Sales Volume by Type (Tons), 2027-2032
Table 23. Global Gamma Valerolactone Revenue by Type (US$ Million), 2021-2026
Table 24. Global Gamma Valerolactone Revenue by Type (US$ Million), 2027-2032
Table 25. Global Gamma Valerolactone Sales Volume by Method (Tons), 2021-2026
Table 26. Global Gamma Valerolactone Sales Volume by Method (Tons), 2027-2032
Table 27. Global Gamma Valerolactone Revenue by Method (US$ Million), 2021-2026
Table 28. Global Gamma Valerolactone Revenue by Method (US$ Million), 2027-2032
Table 29. Global Gamma Valerolactone Sales Volume by Channel (Tons), 2021-2026
Table 30. Global Gamma Valerolactone Sales Volume by Channel (Tons), 2027-2032
Table 31. Global Gamma Valerolactone Revenue by Channel (US$ Million), 2021-2026
Table 32. Global Gamma Valerolactone Revenue by Channel (US$ Million), 2027-2032
Table 33. Technical Specifications by Key Product Type
Table 34. Global Gamma Valerolactone Sales by Application (Tons), 2021-2026
Table 35. Global Gamma Valerolactone Sales by Application (Tons), 2027-2032
Table 36. Gamma Valerolactone High-Growth Sectors Demand CAGR (2026-2032)
Table 37. Global Gamma Valerolactone Revenue by Application (US$ Million), 2021-2026
Table 38. Global Gamma Valerolactone Revenue by Application (US$ Million), 2027-2032
Table 39. Top Customers by Region
Table 40. Top Customers by Application
Table 41. Global Gamma Valerolactone Production by Region (Tons), 2021-2026
Table 42. Global Gamma Valerolactone Production by Region (Tons), 2027-2032
Table 43. North America Gamma Valerolactone Growth Accelerators and Market Barriers
Table 44. North America Gamma Valerolactone Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 45. North America Gamma Valerolactone Sales (Tons) by Country (2021 vs 2025 vs 2032)
Table 46. Europe Gamma Valerolactone Growth Accelerators and Market Barriers
Table 47. Europe Gamma Valerolactone Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Europe Gamma Valerolactone Sales (Tons) by Country (2021 vs 2025 vs 2032)
Table 49. Asia-Pacific Gamma Valerolactone Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 50. Asia-Pacific Gamma Valerolactone Sales (Tons) by Country (2021 vs 2025 vs 2032)
Table 51. Asia-Pacific Gamma Valerolactone Growth Accelerators and Market Barriers
Table 52. Southeast Asia Gamma Valerolactone Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 53. Central and South America Gamma Valerolactone Investment Opportunities and Key Challenges
Table 54. Central and South America Gamma Valerolactone Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 55. Middle East and Africa Gamma Valerolactone Investment Opportunities and Key Challenges
Table 56. Middle East and Africa Gamma Valerolactone Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 57. Soda Aromatic Corporation Information
Table 58. Soda Aromatic Description and Major Businesses
Table 59. Soda Aromatic Product Models, Descriptions and Specifications
Table 60. Soda Aromatic Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 61. Soda Aromatic Sales Value Proportion by Product in 2025
Table 62. Soda Aromatic Sales Value Proportion by Application in 2025
Table 63. Soda Aromatic Sales Value Proportion by Geographic Area in 2025
Table 64. Soda Aromatic Gamma Valerolactone SWOT Analysis
Table 65. Soda Aromatic Recent Developments
Table 66. Anhui Hyea Aromas Corporation Information
Table 67. Anhui Hyea Aromas Description and Major Businesses
Table 68. Anhui Hyea Aromas Product Models, Descriptions and Specifications
Table 69. Anhui Hyea Aromas Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 70. Anhui Hyea Aromas Sales Value Proportion by Product in 2025
Table 71. Anhui Hyea Aromas Sales Value Proportion by Application in 2025
Table 72. Anhui Hyea Aromas Sales Value Proportion by Geographic Area in 2025
Table 73. Anhui Hyea Aromas Gamma Valerolactone SWOT Analysis
Table 74. Anhui Hyea Aromas Recent Developments
Table 75. LangFang Hawk T&D Corporation Information
Table 76. LangFang Hawk T&D Description and Major Businesses
Table 77. LangFang Hawk T&D Product Models, Descriptions and Specifications
Table 78. LangFang Hawk T&D Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 79. LangFang Hawk T&D Sales Value Proportion by Product in 2025
Table 80. LangFang Hawk T&D Sales Value Proportion by Application in 2025
Table 81. LangFang Hawk T&D Sales Value Proportion by Geographic Area in 2025
Table 82. LangFang Hawk T&D Gamma Valerolactone SWOT Analysis
Table 83. LangFang Hawk T&D Recent Developments
Table 84. Chongqing Zoteq Aromachemical Corporation Information
Table 85. Chongqing Zoteq Aromachemical Description and Major Businesses
Table 86. Chongqing Zoteq Aromachemical Product Models, Descriptions and Specifications
Table 87. Chongqing Zoteq Aromachemical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 88. Chongqing Zoteq Aromachemical Sales Value Proportion by Product in 2025
Table 89. Chongqing Zoteq Aromachemical Sales Value Proportion by Application in 2025
Table 90. Chongqing Zoteq Aromachemical Sales Value Proportion by Geographic Area in 2025
Table 91. Chongqing Zoteq Aromachemical Gamma Valerolactone SWOT Analysis
Table 92. Chongqing Zoteq Aromachemical Recent Developments
Table 93. Jiangsu Qingquan Chemical Corporation Information
Table 94. Jiangsu Qingquan Chemical Description and Major Businesses
Table 95. Jiangsu Qingquan Chemical Product Models, Descriptions and Specifications
Table 96. Jiangsu Qingquan Chemical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 97. Jiangsu Qingquan Chemical Sales Value Proportion by Product in 2025
Table 98. Jiangsu Qingquan Chemical Sales Value Proportion by Application in 2025
Table 99. Jiangsu Qingquan Chemical Sales Value Proportion by Geographic Area in 2025
Table 100. Jiangsu Qingquan Chemical Gamma Valerolactone SWOT Analysis
Table 101. Jiangsu Qingquan Chemical Recent Developments
Table 102. Juye Zhongyue Aroma Corporation Information
Table 103. Juye Zhongyue Aroma Description and Major Businesses
Table 104. Juye Zhongyue Aroma Product Models, Descriptions and Specifications
Table 105. Juye Zhongyue Aroma Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 106. Juye Zhongyue Aroma Recent Developments
Table 107. Kunshan Baihua Biotechnology Corporation Information
Table 108. Kunshan Baihua Biotechnology Description and Major Businesses
Table 109. Kunshan Baihua Biotechnology Product Models, Descriptions and Specifications
Table 110. Kunshan Baihua Biotechnology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 111. Kunshan Baihua Biotechnology Recent Developments
Table 112. Inoue Perfumery MFG Corporation Information
Table 113. Inoue Perfumery MFG Description and Major Businesses
Table 114. Inoue Perfumery MFG Product Models, Descriptions and Specifications
Table 115. Inoue Perfumery MFG Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 116. Inoue Perfumery MFG Recent Developments
Table 117. Key Raw Materials Distribution
Table 118. Raw Materials Key Suppliers
Table 119. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 120. Milestones in Production Technology Evolution
Table 121. Distributors List
Table 122. Market Trends and Market Evolution
Table 123. Market Drivers and Opportunities
Table 124. Market Challenges, Risks, and Restraints
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Gamma Valerolactone Product Picture
Figure 2. Global Gamma Valerolactone Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Food Grade Product Picture
Figure 4. Industrial Grade Product Picture
Figure 5. Global Gamma Valerolactone Market Size Growth Rate by Method, 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Chemical Method Product Picture
Figure 7. Biological Method Product Picture
Figure 8. Global Gamma Valerolactone Market Size Growth Rate by Channel, 2021 vs 2025 vs 2032 (US$ Million)
Figure 9. Direct Selling Product Picture
Figure 10. Distribution Product Picture
Figure 11. Global Gamma Valerolactone Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 12. Food Flavors
Figure 13. Solvent
Figure 14. Monomer Intermediate
Figure 15. Others
Figure 16. Gamma Valerolactone Report Years Considered
Figure 17. Global Gamma Valerolactone Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global Gamma Valerolactone Revenue (US$ Million), 2021-2032
Figure 19. Global Gamma Valerolactone Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 20. Global Gamma Valerolactone Revenue-Based Market Share by Region (2021-2032)
Figure 21. Global Gamma Valerolactone Sales (Tons), 2021-2032
Figure 22. Global Gamma Valerolactone Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (Tons)
Figure 23. Global Gamma Valerolactone Sales Market Share by Region (2021-2032)
Figure 24. Global Gamma Valerolactone Capacity, Production and Utilization (Tons), 2021 vs 2025 vs 2032
Figure 25. Top 5 and Top 10 Manufacturers Gamma Valerolactone Sales Volume Market Share in 2025
Figure 26. Global Gamma Valerolactone Revenue-Based Market Share Ranking (2025)
Figure 27. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 28. Food Grade Revenue-Based Market Share by Manufacturer in 2025
Figure 29. Industrial Grade Revenue-Based Market Share by Manufacturer in 2025
Figure 30. Global Gamma Valerolactone Sales Volume-Based Market Share by Type (2021-2032)
Figure 31. Global Gamma Valerolactone Revenue-Based Market Share by Type (2021-2032)
Figure 32. Global Gamma Valerolactone ASP by Type (US$/kg), 2021-2032
Figure 33. Global Gamma Valerolactone Sales Volume-Based Market Share by Method (2021-2032)
Figure 34. Global Gamma Valerolactone Revenue-Based Market Share by Method (2021-2032)
Figure 35. Global Gamma Valerolactone ASP by Method (US$/kg), 2021-2032
Figure 36. Global Gamma Valerolactone Sales Volume-Based Market Share by Channel (2021-2032)
Figure 37. Global Gamma Valerolactone Revenue-Based Market Share by Channel (2021-2032)
Figure 38. Global Gamma Valerolactone ASP by Channel (US$/kg), 2021-2032
Figure 39. Global Gamma Valerolactone Sales Market Share by Application (2021-2032)
Figure 40. Global Gamma Valerolactone Revenue-Based Market Share by Application (2021-2032)
Figure 41. Global Gamma Valerolactone ASP by Application (US$/kg), 2021-2032
Figure 42. Global Gamma Valerolactone Capacity, Production and Utilization (Tons), 2021-2032
Figure 43. Global Gamma Valerolactone Production Market Share by Region (2021-2032)
Figure 44. Production Capacity Enablers & Constraints
Figure 45. Gamma Valerolactone Production Growth Rate in North America (Tons), 2021-2032
Figure 46. Gamma Valerolactone Production Growth Rate in Europe (Tons), 2021-2032
Figure 47. Gamma Valerolactone Production Growth Rate in China (Tons), 2021-2032
Figure 48. Gamma Valerolactone Production Growth Rate in Japan (Tons), 2021-2032
Figure 49. North America Gamma Valerolactone Sales YoY (Tons), 2021-2032
Figure 50. North America Gamma Valerolactone Revenue YoY (US$ Million), 2021-2032
Figure 51. North America Top 5 Manufacturers Gamma Valerolactone Sales Revenue (US$ Million) in 2025
Figure 52. North America Gamma Valerolactone Sales Volume (Tons) by Application (2021-2032)
Figure 53. North America Gamma Valerolactone Sales Revenue (US$ Million) by Application (2021-2032)
Figure 54. US Gamma Valerolactone Revenue (US$ Million), 2021-2032
Figure 55. Canada Gamma Valerolactone Revenue (US$ Million), 2021-2032
Figure 56. Mexico Gamma Valerolactone Revenue (US$ Million), 2021-2032
Figure 57. Europe Gamma Valerolactone Sales YoY (Tons), 2021-2032
Figure 58. Europe Gamma Valerolactone Revenue YoY (US$ Million), 2021-2032
Figure 59. Europe Top 5 Manufacturers Gamma Valerolactone Sales Revenue (US$ Million) in 2025
Figure 60. Europe Gamma Valerolactone Sales Volume (Tons) by Application (2021-2032)
Figure 61. Europe Gamma Valerolactone Sales Revenue (US$ Million) by Application (2021-2032)
Figure 62. Germany Gamma Valerolactone Revenue (US$ Million), 2021-2032
Figure 63. France Gamma Valerolactone Revenue (US$ Million), 2021-2032
Figure 64. U.K. Gamma Valerolactone Revenue (US$ Million), 2021-2032
Figure 65. Italy Gamma Valerolactone Revenue (US$ Million), 2021-2032
Figure 66. Russia Gamma Valerolactone Revenue (US$ Million), 2021-2032
Figure 67. Asia-Pacific Gamma Valerolactone Sales YoY (Tons), 2021-2032
Figure 68. Asia-Pacific Gamma Valerolactone Revenue YoY (US$ Million), 2021-2032
Figure 69. Asia-Pacific Top 8 Manufacturers Gamma Valerolactone Sales Revenue (US$ Million) in 2025
Figure 70. Asia-Pacific Gamma Valerolactone Sales Volume (Tons) by Application (2021-2032)
Figure 71. Asia-Pacific Gamma Valerolactone Sales Revenue (US$ Million) by Application (2021-2032)
Figure 72. Indonesia Gamma Valerolactone Revenue (US$ Million), 2021-2032
Figure 73. Japan Gamma Valerolactone Revenue (US$ Million), 2021-2032
Figure 74. South Korea Gamma Valerolactone Revenue (US$ Million), 2021-2032
Figure 75. China Taiwan Gamma Valerolactone Revenue (US$ Million), 2021-2032
Figure 76. India Gamma Valerolactone Revenue (US$ Million), 2021-2032
Figure 77. Central and South America Gamma Valerolactone Sales YoY (Tons), 2021-2032
Figure 78. Central and South America Gamma Valerolactone Revenue YoY (US$ Million), 2021-2032
Figure 79. Central and South America Top 5 Manufacturers Gamma Valerolactone Sales Revenue (US$ Million) in 2025
Figure 80. Central and South America Gamma Valerolactone Sales Volume (Tons) by Application (2021-2032)
Figure 81. Central and South America Gamma Valerolactone Sales Revenue (US$ Million) by Application (2021-2032)
Figure 82. Brazil Gamma Valerolactone Revenue (US$ Million), 2021-2032
Figure 83. Argentina Gamma Valerolactone Revenue (US$ Million), 2021-2032
Figure 84. Middle East, and Africa Gamma Valerolactone Sales YoY (Tons), 2021-2032
Figure 85. Middle East and Africa Gamma Valerolactone Revenue YoY (US$ Million), 2021-2032
Figure 86. Middle East and Africa Top 5 Manufacturers Gamma Valerolactone Sales Revenue (US$ Million) in 2025
Figure 87. Middle East and Africa Gamma Valerolactone Sales Volume (Tons) by Application (2021-2032)
Figure 88. Middle East and Africa Gamma Valerolactone Sales Revenue (US$ Million) by Application (2021-2032)
Figure 89. GCC Countries Gamma Valerolactone Revenue (US$ Million), 2021-2032
Figure 90. Turkey Gamma Valerolactone Revenue (US$ Million), 2021-2032
Figure 91. Egypt Gamma Valerolactone Revenue (US$ Million), 2021-2032
Figure 92. South Africa Gamma Valerolactone Revenue (US$ Million), 2021-2032
Figure 93. Gamma Valerolactone Industry Chain Mapping
Figure 94. Regional Gamma Valerolactone Manufacturing Base Distribution (%)
Figure 95. Gamma Valerolactone Production Process
Figure 96. Regional Gamma Valerolactone Production Cost Structure
Figure 97. Channels of Distribution (Direct Vs Distribution)
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 2.8% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
Which companies rank high in the global Gamma Valerolactone market?
What is the annual compound growth rate of the global Gamma Valerolactone market size from 2026 to 2032?
What was the global market size of Gamma Valerolactone in 2026?
What was the global market size of Gamma Valerolactone in 2032?
Related Reports
Global Gamma Valerolactone Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Gamma Valerolactone (CAS 108-29-2) is colorless liquid. It is one of the more common lactones. GVL is chiral but is usually used as the racemate. It can be used to produce food flavors, used as solvent for resins, monomer intermediate, lubricant, plasticizer and so on.
Published Date: 2024-04-17
Pages: 151
USD 5600.00
(Single User License)
Global Gamma Valerolactone Market Research Report 2025
The global market for Gamma Valerolactone was valued at US$ 509 million in the year 2024 and is projected to reach a revised size of US$ 651 million by 2031, growing at a CAGR of 1.3% during the forecast period.
Published Date: 2025-09-12
Pages: 94
USD 2900.00
(Single User License)
Gamma Valerolactone- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Gamma Valerolactone was estimated to be worth US$ 741 million in 2024 and is forecast to a readjusted size of US$ 725 million by 2031 with a CAGR of -0.3% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 95
USD 3950.00
(Single User License)
Global Gamma Valerolactone Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Gamma Valerolactone was estimated to be worth US$ 741 million and is forecast to reach approximately US$ 725 million by 2031 with a CAGR of -0.3% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 125
USD 5900.00
(Single User License)
Global Gamma Valerolactone Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Gamma Valerolactone market size was US$ 509 million in 2024 and is forecast to a readjusted size of US$ 651 million by 2031 with a CAGR of 1.3% during the forecast period 2025-2031.
Published Date: 2025-09-12
Pages: 78
USD 4250.00
(Single User License)
Global Gamma Valerolactone Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Gamma Valerolactone market is projected to grow from US$ 509 million in 2024 to US$ 651 million by 2031, at a CAGR of 1.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-12
Pages: 136
USD 4900.00
(Single User License)
Gamma Valerolactone - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Gamma Valerolactone was estimated to be worth US$ 509 million in 2024 and is forecast to a readjusted size of US$ 651 million by 2031 with a CAGR of 1.3% during the forecast period 2025-2031.
Published Date: 2025-10-15
Pages: 109
USD 3950.00
(Single User License)
Gamma Valerolactone- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Gamma Valerolactone was estimated to be worth US$ 603 million in 2025 and is projected to reach US$ 731 million, growing at a CAGR of 2.8% from 2026 to 2032.
Published Date: 2026-08-07
Pages: 135
USD 3950.00
(Single User License)
Global Gamma Valerolactone Market Research Report 2026
The global Gamma Valerolactone market was valued at US$ 603 million in 2025 and is anticipated to reach US$ 731 million by 2032, at a CAGR of 2.8% from 2026 to 2032.
Published Date: 2026-08-07
Pages: 133
USD 2900.00
(Single User License)
Global Gamma Valerolactone Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Gamma Valerolactone market size was US$ 603 million in 2025 and is forecast to reach a readjusted size of US$ 731 million by 2032 with a CAGR of 2.8% during the forecast period 2026-2032.
Published Date: 2026-08-07
Pages: 128
USD 4250.00
(Single User License)
Global Gamma Valerolactone Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Gamma Valerolactone (CAS 108-29-2) is colorless liquid. It is one of the more common lactones. GVL is chiral but is usually used as the racemate. It can be used to produce food flavors, used as solvent for resins, monomer intermediate, lubricant, plasticizer and so on.
Published: 2024-04-17
Pages: 151
USD 5600.00 (Single User License)Global Gamma Valerolactone Market Research Report 2025
The global market for Gamma Valerolactone was valued at US$ 509 million in the year 2024 and is projected to reach a revised size of US$ 651 million by 2031, growing at a CAGR of 1.3% during the forecast period.
Published: 2025-09-12
Pages: 94
USD 2900.00 (Single User License)Gamma Valerolactone- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Gamma Valerolactone was estimated to be worth US$ 741 million in 2024 and is forecast to a readjusted size of US$ 725 million by 2031 with a CAGR of -0.3% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 95
USD 3950.00 (Single User License)Global Gamma Valerolactone Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Gamma Valerolactone was estimated to be worth US$ 741 million and is forecast to reach approximately US$ 725 million by 2031 with a CAGR of -0.3% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 125
USD 5900.00 (Single User License)Global Gamma Valerolactone Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Gamma Valerolactone market size was US$ 509 million in 2024 and is forecast to a readjusted size of US$ 651 million by 2031 with a CAGR of 1.3% during the forecast period 2025-2031.
Published: 2025-09-12
Pages: 78
USD 4250.00 (Single User License)Global Gamma Valerolactone Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Gamma Valerolactone market is projected to grow from US$ 509 million in 2024 to US$ 651 million by 2031, at a CAGR of 1.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-12
Pages: 136
USD 4900.00 (Single User License)Gamma Valerolactone - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Gamma Valerolactone was estimated to be worth US$ 509 million in 2024 and is forecast to a readjusted size of US$ 651 million by 2031 with a CAGR of 1.3% during the forecast period 2025-2031.
Published: 2025-10-15
Pages: 109
USD 3950.00 (Single User License)Gamma Valerolactone- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Gamma Valerolactone was estimated to be worth US$ 603 million in 2025 and is projected to reach US$ 731 million, growing at a CAGR of 2.8% from 2026 to 2032.
Published: 2026-08-07
Pages: 135
USD 3950.00 (Single User License)Global Gamma Valerolactone Market Research Report 2026
The global Gamma Valerolactone market was valued at US$ 603 million in 2025 and is anticipated to reach US$ 731 million by 2032, at a CAGR of 2.8% from 2026 to 2032.
Published: 2026-08-07
Pages: 133
USD 2900.00 (Single User License)Global Gamma Valerolactone Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Gamma Valerolactone market size was US$ 603 million in 2025 and is forecast to reach a readjusted size of US$ 731 million by 2032 with a CAGR of 2.8% during the forecast period 2026-2032.
Published: 2026-08-07
Pages: 128
USD 4250.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report